The COVID-19 Treatment Guidelines were developed to provide clinicians with guidance on caring for
patients with COVID-19. Because clinical information about the optimal management of COVID-19
is evolving quickly, these Guidelines are updated frequently to reflect newly published data and other
authorita...
Evidence-based recommendations on maribavir (Livtencity) for cytomegalovirus infection in adults after transplant.
Commercial arrangement
There is a simple discount patient access scheme for maribavir. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisat...
Barbosa, Alexandre Naime;
Chebabo, Alberto;
Pérez, Clevy;
Cunha, Clóvis Arns;
Luna, David de;
Nunes, Estevão Portela;
Zambrano, Gabriela;
Ferreira, Juliana Carvalho;
Croda, Júlio;
Falavigna, Maicon;
Silva, Monica Maria Gomes da;
Cimerman, Sergio;
Parahiba, Suena Medeiros;
Tanni, Suzana;
Bernardo, Wanderley Marques;
Rodriguez-Morales, Alfonso J.
Since the beginning of the COVID-19 pandemic, therapeutic options for treating COVID-19 have been investigated at different stages of clinical manifestations. Considering the particular impact of COVID-19 in the Americas, this document aims to present recommendations for the pharmacological treatment of ...
